TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs. Liao Q, Zhang R, Ou Z, Ye Y, et al. Mol Ther Oncol 2024;32:200762.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liao Q, Zhang R, Ou Z, Ye Y, et al. TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs. Mol Ther Oncol 2024;32:200762.
PMID: 38596285